Tethering: Fragment-Based Drug Discovery

A Combinatorial Approach Defines Specificities of Members of the Caspase Family and Granzyme B

Thornberry, N. A., Rano, T. A., Peterson, E. P., Rasper, D., Timkey, T., Garcia-Calvo, M. M., Houtzager, V. M., Nordstrom, P. A., Roy, S., Vaillancourt, J. P., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.29.17907 · Cited by 2,072 · see citing works

Discovering High-Affinity Ligands for Proteins: SAR by NMR

Shuker, S. B., Hajduk, P. J., Meadows, R. P., & Fesik, S. W. (1996) · Science · doi:10.1126/science.274.5292.1531 · Cited by 2,045 · see citing works

Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase

Schindler, T. H., Bornmann, W. G., Pellicena, P., Miller, W. T., Clarkson, B., & Kuriyan, J. (2000) · Science · doi:10.1126/science.289.5486.1938 · Cited by 1,785 · see citing works

The Conformational Plasticity of Protein Kinases

Huse, M., & Kuriyan, J. (2002) · Cell · doi:10.1016/s0092-8674(02)00741-9 · Cited by 1,760 · see citing works

Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases

Powers, J. C., Asgian, J. L., Ekici, Ö. D., & James, K. E. (2002) · Chemical Reviews · doi:10.1021/cr010182v · Cited by 1,090 · cited 1× · see citing works

A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening

McGovern, S. L., Caselli, E., Grigorieff, N., & Shoichet, B. K. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010533y · Cited by 1,048 · see citing works

Inhibition of Human Caspases by Peptide-based and Macromolecular Inhibitors

Garcia-Calvo, M. M., Peterson, E. P., Leiting, B., Ruel, R., Nicholson, D. W., & Thornberry, N. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32608 · Cited by 980 · see citing works

On the attribution and additivity of binding energies

Jencks, W. P. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.7.4046 · Cited by 914 · see citing works

Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site

Pargellis, C., Tong, L., Churchill, L., Cirillo, P. F., Gilmore, T., Graham, A. G., Grob, P. M., Hickey, E. R., Moss, N., Pav, S., et al. (2002) · Nature Structural Biology · doi:10.1038/nsb770 · Cited by 834 · see citing works

Unraveling hot spots in binding interfaces: progress and challenges

DeLano, W. L. (2002) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(02)00283-x · Cited by 767 · see citing works

Cysteine Proteases and Their Inhibitors

Otto, H., & Schirmeister, T. (1997) · Chemical Reviews · doi:10.1021/cr950025u · Cited by 760 · see citing works

Protein tyrosine phosphatase 1B inhibitors for diabetes

Johnson, T., Ermolieff, J., & Jirousek, M. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd895 · Cited by 660 · see citing works

[2] Thiol/disulfide exchange equilibria and disulfidebond stability

Gilbert, H. (1995) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(95)51107-5 · Cited by 549 · see citing works

High-throughput crystallography for lead discovery in drug design

Blundell, T. L., Jhoti, H., & Abell, C. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd706 · Cited by 529 · see citing works

Drug discovery by dynamic combinatorial libraries

Ramström, O., & Lehn, J. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd704 · Cited by 510 · see citing works

Regulation of PTP1B via Glutathionylation of the Active Site Cysteine 215

Barrett, W. C., DeGnore, J. P., König, S., Fales, H. M., Keng, Y., Zhang, Z., Yim, M. B., & Chock, P. B. (1999) · Biochemistry · doi:10.1021/bi990240v · Cited by 488 · see citing works

Biology of the Interleukin-2 Receptor

Nelson, B. H., & Willerford, D. M. (1998) · Advances in immunology · doi:10.1016/s0065-2776(08)60386-7 · Cited by 475 · see citing works

Preferential Heterodimer Formation by Isolated Leucine Zippers from Fos and Jun

O’Shea, E. K., Rutkowski, R., Stafford, W. F., & Kim, P. S. (1989) · Science · doi:10.1126/science.2503872 · Cited by 471 · see citing works

Molecular Basis for the Dephosphorylation of the Activation Segment of the Insulin Receptor by Protein Tyrosine Phosphatase 1B

Salmeen, A. E., Andersen, J. N., Myers, M. P., Tonks, N. K., & Barford, D. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00137-4 · Cited by 470 · see citing works

Site-directed ligand discovery

Erlanson, D. A., Braisted, A. C., Raphael, D. R., Randal, M., Stroud, R. M., Gordon, E. M., & Wells, J. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9367 · Cited by 466 · see citing works

Virtual combinatorial libraries: Dynamic generation of molecular and supramolecular diversity by self-assembly

Huc, I., & Lehn, J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2106 · Cited by 461 · see citing works

Protein Tyrosine Phosphatases: Structure and Function, Substrate Specificity, and Inhibitor Development

Zhang, Z. (2002) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.083001.144616 · Cited by 435 · see citing works

Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor

Fry, D. W., Bridges, A. J., Denny, W. A., Doherty, A. M., Greis, K. D., Hicks, J. L., Hook, K. E., Keller, P. R., Leopold, W. R., Loo, J. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.12022 · Cited by 424 · see citing works

Dynamic Combinatorial Chemistry

Lehn, J., & Eliseev, A. V. (2001) · Science · doi:10.1126/science.1060066 · Cited by 403 · see citing works

Nonleadlikeness and leadlikeness in biochemical screening

Rishton, G. M. (2003) · Drug Discovery Today · doi:10.1016/s1359644602025722 · Cited by 381 · see citing works

Novel Inhibitors of DNA Gyrase: 3D Structure Based Biased Needle Screening, Hit Validation by Biophysical Methods, and 3D Guided Optimization. A Promising Alternative to Random Screening

Boehm, H.-J., Boehringer, M., Bur, D., Gmuender, H., Huber, W., Klaus, W., Kostrewa, D., Kuehne, H., Luebbers, T., Meunier-Keller, N., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000017s · Cited by 376 · see citing works

Binding of small molecules to an adaptive protein–protein interface

Arkin, M. R., Randal, M., DeLano, W. L., Hyde, J., Luong, T. N., Oslob, J. D., Raphael, D. R., Taylor, L., Wang, J., McDowell, R. S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252756299 · Cited by 376 · see citing works

Discovering novel ligands for macromolecules using X-ray crystallographic screening

Nienaber, V. L., Richardson, P. L., Klighofer, V., Bouska, J. J., Giranda, V. L., & Greer, J. (2000) · Nature Biotechnology · doi:10.1038/80319 · Cited by 322 · see citing works

Inhibition of Protein−Protein Association by Small Molecules: Approaches and Progress

Toogood, P. L. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010468s · Cited by 281 · see citing works

The SHAPES strategy: an NMR-based approach for lead generation in drug discovery

Fejzo, J., Lepre, C. A., Peng, J. W., Bemis, G. W., Ajay, Murcko, M. A., & Moore, J. M. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(00)80022-8 · Cited by 276 · see citing works

6-Substituted-4-(3-bromophenylamino)quinazolines as Putative Irreversible Inhibitors of the Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor (HER-2) Tyrosine Kinases with Enhanced Antitumor Activity

Tsou, H., Mamuya, N. N., Johnson, B. D., Reich, M. F., Gruber, B. C., Ye, F., Nilakantan, R., Shen, R., Discafani, C. M., DeBlanc, R., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0005555 · Cited by 269 · see citing works

Discovery of a Potent Small Molecule IL-2 Inhibitor through Fragment Assembly

Braisted, A. C., Oslob, J. D., DeLano, W. L., Hyde, J., McDowell, R. S., Waal, N. D., Yu, C. H., Arkin, M. R., & Raimundo, B. C. (2003) · Journal of the American Chemical Society · doi:10.1021/ja034247i · Cited by 256 · see citing works

Substrate and Inhibitor Specificity of Interleukin-1β-converting Enzyme and Related Caspases

Margolin, N., Raybuck, S. A., Wilson, K. P., Chen, W., Fox, T., Gu, Y., & Livingston, D. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.7223 · Cited by 244 · see citing works

Structure-reactivity relations for thiol-disulfide interchange

Houk, J., & Whitesides, G. M. (1987) · Journal of the American Chemical Society · doi:10.1021/ja00256a040 · Cited by 238 · see citing works

In situ assembly of enzyme inhibitors using extended tethering

Erlanson, D. A., Lam, J. W., Wiesmann, C., Luong, T. N., Simmons, R. L., DeLano, W. L., Choong, I., Burdett, M. T., Flanagan, W. M., Lee, D. M., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt786 · Cited by 204 · see citing works

SAR by MS: A Ligand Based Technique for Drug Lead Discovery Against Structured RNA Targets

Swayze, E. E., Jefferson, E. A., Sannes, K. A., Blyn, L. B., Risen, L. M., Arakawa, S., Osgood, S. A., Hofstadler, S. A., & Griffey, R. H. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0255466 · Cited by 145 · see citing works

P1 Aspartate-Based Peptide .alpha.-((2,6-Dichlorobenzoyl)oxy)methyl Ketones as Potent Time-Dependent Inhibitors of Interleukin-1.beta.-Converting Enzyme

Dolle, R. E., Hoyer, D., Prasad, C. V. C., Schmidt, S. J., Helaszek, C. T., Miller, R. E., & Ator, M. A. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00031a003 · Cited by 143 · see citing works

A Minimal Peptide Scaffold for β-Turn Display: Optimizing a Strand Position in Disulfide-Cyclized β-Hairpins

Cochran, A. G., Tong, R. T., Starovasnik, M. A., Park, E. J., McDowell, R. S., Theaker, J., & Skelton, N. J. (2000) · Journal of the American Chemical Society · doi:10.1021/ja003369x · Cited by 136 · see citing works

Discovery and SAR of a Novel Selective and Orally Bioavailable Nonpeptide Classical Competitive Inhibitor Class of Protein-Tyrosine Phosphatase 1B

Andersen, H. S., Olsen, O. H., Iversen, L. F., Sørensen, A. L. P., Mortensen, S. B., Christensen, M. S., Branner, S., Hansen, T. K., Lau, J. F., Jeppesen, L., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0209026 · Cited by 135 · see citing works

Kinetics and equilibria of thiol/disulfide interchange reactions of selected biological thiols and related molecules with oxidized glutathione

Keire, D. A., Strauss, E. J., Guo, W., Noszál, B., & Rabenstein, D. L. (1992) · The Journal of Organic Chemistry · doi:10.1021/jo00027a023 · Cited by 134 · see citing works

Protein–protein interfaces: mimics and inhibitors

Cochran, A. G. (2001) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(01)00262-9 · Cited by 133 · see citing works

Identification of a Small Molecule Inhibitor of the IL-2/IL-2Rα Receptor Interaction Which Binds to IL-2

Tilley, J., Chen, L., Fry, D. C., Emerson, S. D., Powers, G. D., Biondi, D. A., Varnell, T. A., Trilles, R. V., Guthrie, R. W., Mennona, F. A., et al. (1997) · Journal of the American Chemical Society · doi:10.1021/ja970702x · Cited by 129 · see citing works

α-Haloacetophenone Derivatives As Photoreversible Covalent Inhibitors of Protein Tyrosine Phosphatases

Arabacı, G., Guo, X., Beebe, K. D., Coggeshall, K. M., & Pei, D. (1999) · Journal of the American Chemical Society · doi:10.1021/ja9906756 · Cited by 124 · see citing works

Structural Basis of Plasticity in Protein Tyrosine Phosphatase 1B Substrate Recognition,

Sarmiento, M., Puius, Y. A., Vetter, S. W., Keng, Y., Wu, L., Zhao, Y. C., Lawrence, D. S., Almo, S. C., & Zhang, Z. (2000) · Biochemistry · doi:10.1021/bi000319w · Cited by 119 · see citing works

Identification of Potent and Selective Small-Molecule Inhibitors of Caspase-3 through the Use of Extended Tethering and Structure-Based Drug Design

Choong, I., Lew, W., Lee, D. M., Pham, P., Burdett, M. T., Lam, J. W., Wiesmann, C., Luong, T. N., Fahr, B. J., DeLano, W. L., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020230j · Cited by 106 · see citing works

Potent Small-Molecule Binding to a Dynamic Hot Spot on IL-2

Thanos, C. D., Randal, M., & Wells, J. A. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0382617 · Cited by 105 · see citing works

Mode of interaction of .beta.-hydroxy-.beta.-methylglutaryl coenzyme A reductase with strong binding inhibitors: compactin and related compounds

Nakamura, C. E., & Abeles, R. H. (1985) · Biochemistry · doi:10.1021/bi00327a014 · Cited by 105 · see citing works

Localization in human interleukin 2 of the binding site to the alpha chain (p55) of the interleukin 2 receptor.

Sauvé, K., Nachman-Clewner, M., Spence, C. L., Bailon, P., Campbell, E., Tsien, W. H., Kondas, J. A., Hakimi, J., & Ju, G. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4636 · Cited by 100 · see citing works

Affinity Selection and Mass Spectrometry-Based Strategies to Identify Lead Compounds in Combinatorial Libraries

Kaur, S., McGuire, L., Tang, D., Dollinger, G., & Huebner, V. (1997) · Journal of Protein Chemistry · doi:10.1023/a:1026369729393 · Cited by 95 · see citing works

SAR and X-ray. A New Approach Combining Fragment-Based Screening and Rational Drug Design: Application to the Discovery of Nanomolar Inhibitors of Src SH2

Lesuisse, D., Lange, G., Deprez, P., Bénard, D., Schoot, B. M., Delettre, G., Marquette, J.-P., Broto, P., Jean‐Baptiste, V., Bichet, P., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010927p · Cited by 90 · see citing works

Phosphoryltyrosyl mimetics in the design of peptide-based signal transduction inhibitors

Burke, T. R., Yao, Z., Liu, D., Voigt, J. H., & Gao, Y. (2001) · Biopolymers · doi:10.1002/1097-0282(2001)60:1 · Cited by 87 · see citing works

Definition and spatial location of mouse interleukin‐2 residues that interact with its heterotrimeric receptor.

Zurawski, S., Vega, F., Doyle, E. L., Huyghe, B. G., Flaherty, K. M., McKay, D., & Zurawski, G. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06206.x · Cited by 82 · see citing works

Mechanism-Based Inactivation of Prostatic Acid Phosphatase

Myers, J. K., & Widlanski, T. S. (1993) · Science · doi:10.1126/science.8248785 · Cited by 78 · see citing works

The additivity of substrate fragments in enzyme–ligand binding

Stout, T. J., Sage, C. R., & Stroud, R. M. (1998) · Structure · doi:10.1016/s0969-2126(98)00086-0 · Cited by 77 · see citing works

Recent advances in the synthesis, design and selection of cysteine protease inhibitors

Hernández, A. Á., & Roush, W. R. (2002) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00345-9 · Cited by 72 · see citing works

Structure-based screening and design in drug discovery

van Dongen, M. J. P., Weigelt, J., Uppenberg, J., Schultz, J., & Wikström, M. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02233-x · Cited by 71 · see citing works

Use of Strain in a Stereospecific Catalytic Mechanism: Crystal Structures of Escherichia coli Thymidylate Synthase Bound to FdUMP and Methylenetetrahydrofolate,

Hyatt, D. C., Maley, F., & Montfort, W. R. (1997) · Biochemistry · doi:10.1021/bi962936j · Cited by 68 · see citing works

Second-Site NMR Screening and Linker Design

Jahnke, W., Flörsheimer, A., Blommers, M. J. J., PARIS, C. G., Heim, J., Nalin, C. M., & Perez, L. B. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033392778 · Cited by 66 · see citing works

Discovery and Structure−Activity Relationship of Oxalylarylaminobenzoic Acids as Inhibitors of Protein Tyrosine Phosphatase 1B

Liu, G., Szczepankiewicz, B. G., Pei, Z., Janowick, D. A., Xin, Z., Hajduk, P. J., Abad‐Zapatero, C., Liang, H., Hutchins, C. W., Fesik, S. W., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0205696 · Cited by 64 · see citing works

Application of NMR Screening in Drug Discovery

Fejzo, J., Lepre, C. A., & Xie, X. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033392796 · Cited by 56 · see citing works

Structural basis for recognition of polyglutamyl folates by thymidylate synthase

Kamb, A., Finer-Moore, J. S., Calvert, H., & Stroud, R. M. (1992) · Biochemistry · doi:10.1021/bi00156a005 · Cited by 54 · see citing works

Peptide Library Approach with a Disulfide Tether to Refine the Tom20 Recognition Motif in Mitochondrial Presequences

Obita, T., Muto, T., Endo, T., & Kohda, D. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00288-2 · Cited by 53 · see citing works

Discovery and Characterization of Cooperative Ligand Binding in the Adaptive Region of Interleukin-2

Hyde, J., Braisted, A. C., Randal, M., & Arkin, M. R. (2003) · Biochemistry · doi:10.1021/bi034138g · Cited by 49 · see citing works

Discovery of a New Phosphotyrosine Mimetic for PTP1B Using Breakaway Tethering

Erlanson, D. A., McDowell, R. S., He, M. M., Randal, M., Simmons, R. L., Kung, J., Waight, A. B., & Hansen, S. K. (2003) · Journal of the American Chemical Society · doi:10.1021/ja034440c · Cited by 48 · see citing works

Structure-Based Screening As Applied to Human FABP4: A Highly Efficient Alternative to HTS for Hit Generation

van Dongen, M. J. P., Uppenberg, J., Svensson, S., Lundbäck, T., Åkerud, T., Wikström, M., & Schultz, J. (2002) · Journal of the American Chemical Society · doi:10.1021/ja017830c · Cited by 48 · see citing works

Design and Synthesis of Potent Non-Polyglutamatable Quinazoline Antifolate Thymidylate Synthase Inhibitors

Marsham, P. R., Wardleworth, J. M., Boyle, F. T., Hennequin, L. F., Kimbell, R., Brown, M., & Jackman, A. L. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9803727 · Cited by 46 · see citing works

Design of Small Molecule Libraries for NMR Screening and Other Applications in Drug Discovery

Jacoby, E., Davies, J. W., & Blommers, M. J. J. (2002) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033392606 · Cited by 44 · see citing works

Apoptosis: a potential target for discovering novel therapies for cardiovascular diseases

Yue, T., Ohlstein, E. H., & Ruffolo, R. R., Jr. (1999) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)80069-6 · Cited by 43 · see citing works

Structure-based studies on species-specific inhibition of thymidylate synthase

Costi, M. P., Tondi, D., Rinaldi, M., Barlocco, D., Pecorari, P., Soragni, F., Venturelli, A., & Stroud, R. M. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00083-2 · Cited by 37 · see citing works

Deconstruction of GCN4/GCRE into a monomeric peptide-DNA complex

Stanojević, D., & Verdine, G. (1995) · Nature Structural Biology · doi:10.1038/nsb0695-450 · Cited by 34 · see citing works

In vitro characterization of nonpeptide irreversible inhibitors of HIV proteases.

Salto, R., Babé, L. M., Li, J., Rose, J., Yu, Z., Burlingame, A. L., Voss, J. J. D., SUI, Z., de Montellano, P. R. O., & Craik, C. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34114-5 · Cited by 32 · see citing works

Design and Synthesis of Non-peptidic Inhibitors for the Syk C-Terminal SH2 Domain Based on Structure-Based In-Silico Screening

Niimi, T., Orita, M., Okazawa-Igarashi, M., Sakashita, H., Kikuchi, K., Ball, E., Ichikawa, A., Yamagiwa, Y., Sakamoto, S., Tanaka, A., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010313k · Cited by 29 · see citing works

Identification of potent and novel small-Molecule inhibitors of caspase-3

Allen, D. A., Pham, P., Choong, I., Fahr, B. J., Burdett, M. T., Lew, W., DeLano, W. L., Gordon, E. M., Lam, J. W., O'Brien, T., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.08.024 · Cited by 27 · see citing works

Selective inactivation of protein tyrosine phosphatase PTP1B by sulfone analogue of naphthoquinone

Ham, S. W., Park, J., Lee, S., & Yoo, J. S. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00725-2 · Cited by 14 · see citing works

Caspase inhibitors - A chemist's perspective.

Graczyk, P. P. (1999) · PubMed · Cited by 13 · see citing works

Emerging therapeutic targets in caspase-dependent disease

McBride, C. B., McPhail, L. T., & Steeves, J. D. (1999) · Emerging Therapeutic Targets · doi:10.1517/14728222.3.3.391 · Cited by 13 · see citing works

A Novel Strategy for Designing Irreversible Inhibitors of Metalloproteases: Acetals as Latent Electrophiles That Interact with Catalytic Nucleophile at the Active Site

Han, M. S., Ryu, C. H., Chung, S. J., & Kim, D. H. (2000) · Organic Letters · doi:10.1021/ol006346w · Cited by 7 · see citing works

The art and practice of structure-based drug design: A molecular modeling perspective

(1996) · doi:10.1002/(sici)1098-1128(199601)16:1

A decade of fragment-based drug design: strategic advances and lessons learned

Hajduk, P. J., & Greer, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2220 · Cited by 1,068 · see citing works

Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality

Arkin, M. R., Tang, Y., & Wells, J. A. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.09.001 · Cited by 1,065 · see citing works

Navigating chemical space for biology and medicine

Lipinski, C. A., & Hopkins, A. L. (2004) · Nature · doi:10.1038/nature03193 · Cited by 1,008 · see citing works

Advances in covalent drug discovery

Boike, L., Henning, N. J., & Nomura, D. K. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00542-z · Cited by 823 · see citing works

Allosteric regulation and catalysis emerge via a common route

Goodey, N. M., & Benkovic, S. J. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.98 · Cited by 661 · see citing works

Fragment-Based Drug Discovery

Erlanson, D. A., McDowell, R. S., & O'Brien, T. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040031v · Cited by 645 · see citing works

Flexible nets: disorder and induced fit in the associations of p53 and 14-3-3 with their partners

Oldfield, C. J., Meng, J., Yang, J. Y., Yang, M. Q., Uversky, V. N., & Dunker, A. K. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-s1-s1 · Cited by 594 · see citing works

Nucleophilic Catalysis of Hydrazone Formation and Transimination: Implications for Dynamic Covalent Chemistry

Dirksen, A., Dirksen, S., Hackeng, T. M., & Dawson, P. E. (2006) · Journal of the American Chemical Society · doi:10.1021/ja067189k · Cited by 431 · see citing works

Perspectives on NMR in drug discovery: a technique comes of age

Pellecchia, M., Bertini, I., Cowburn, D., Dalvit, C., Giralt, E., Jahnke, W., James, T. L., Homans, S. W., Kessler, H., Luchinat, C., et al. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2606 · Cited by 417 · see citing works

MOLECULAR MECHANISM OF 7TM RECEPTOR ACTIVATION—A GLOBAL TOGGLE SWITCH MODEL

Schwartz, T. W., Frimurer, T. M., Holst, B., ROSENKILDE, M. M., & Elling, C. (2006) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141218 · Cited by 407 · see citing works

High-Throughput Screening: today’s biochemical and cell-based approaches

Blay, V., Tolani, B., Ho, S. P., & Arkin, M. R. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.07.024 · Cited by 404 · see citing works

Targeting protein–protein interactions as an anticancer strategy

Ivanov, A. A., Khuri, F. R., & Fu, H. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.04.007 · Cited by 401 · see citing works

Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer

Kawasaki, E. S., & Player, A. N. (2005) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2005.03.002 · Cited by 366 · see citing works

Advances in Bioconjugation

Kalia, J., & Raines, R. T. (2009) · Current Organic Chemistry · doi:10.2174/138527210790069839 · Cited by 360 · see citing works

Ras Conformational Ensembles, Allostery, and Signaling

Lu, S., Jang, H., Muratcioglu, S., Gursoy, A., Keskin, O., Nussinov, R., & Zhang, J. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00542 · Cited by 355 · see citing works

Dynamic combinatorial/covalent chemistry: a tool to read, generate and modulate the bioactivity of compounds and compound mixtures

Herrmann, A. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60336a · Cited by 350 · see citing works

Fragment-based lead discovery: leads by design

Carr, R. A. E., Congreve, M., Murray, C. W., & Rees, D. C. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03511-7 · Cited by 343 · see citing works

Rapid Covalent-Probe Discovery by Electrophile-Fragment Screening

Resnick, E., Bradley, A., Gan, J., Douangamath, A., Krojer, T., Sethi, R., Geurink, P. P., Aimon, A., Amitai, G., Bellini, D., et al. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b02822 · Cited by 335 · see citing works

Oncogenic protein interfaces: small molecules, big challenges

Nero, T. L., Morton, C. J., Holien, J. K., Wielens, J., & Parker, M. W. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3690 · Cited by 312 · see citing works

The pharmacological landscape and therapeutic potential of serine hydrolases

Bachovchin, D. A., & Cravatt, B. F. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3620 · Cited by 307 · see citing works

Dependence of Effective Molarity on Linker Length for an Intramolecular Protein−Ligand System

Krishnamurthy, V. M., Semetey, V., Bracher, P. J., Shen, N., & Whitesides, G. M. (2007) · Journal of the American Chemical Society · doi:10.1021/ja066780e · Cited by 298 · see citing works

Chemical Genetics

Walsh, D. P., & Chang, Y. (2006) · Chemical Reviews · doi:10.1021/cr0404141 · Cited by 296 · see citing works

The impact of click chemistry in medicinal chemistry

Hou, J., Liu, X., Shen, J., Zhao, G., & Wang, P. G. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.682725 · Cited by 294 · see citing works

Features of protein–protein interactions that translate into potent inhibitors: topology, surface area and affinity

Smith, M. C. P., & Gestwicki, J. E. (2012) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2012.10 · Cited by 285 · see citing works

Introduction to Fragment-Based Drug Discovery

Erlanson, D. A. (2011) · Topics in current chemistry · doi:10.1007/128_2011_180 · Cited by 268 · see citing works

Design Principles for Fragment Libraries: Maximizing the Value of Learnings from Pharma Fragment-Based Drug Discovery (FBDD) Programs for Use in Academia

Keserű, G. M., Erlanson, D. A., Ferenczy, G. G., Hann, M. M., Murray, C. W., & Pickett, S. D. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00197 · Cited by 244 · see citing works

Discovery of an allosteric site in the caspases

Hardy, J. A., Lam, J. W., Nguyen, J. T., O'Brien, T., & Wells, J. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404781101 · Cited by 236 · see citing works

Molecular dynamics in drug design

Zhao, H., & Caflisch, A. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.08.004 · Cited by 230 · see citing works

Dynamic combinatorial chemistry: a tool to facilitate the identification of inhibitors for protein targets

Mondal, M., & Hirsch, A. K. H. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00493k · Cited by 216 · see citing works

Fragment-based drug discovery using NMR spectroscopy

Harner, M. J., Frank, A. O., & Fesik, S. W. (2013) · Journal of Biomolecular NMR · doi:10.1007/s10858-013-9740-z · Cited by 213 · see citing works

Cryptic binding sites on proteins: definition, detection, and druggability

Vajda, S., Beglov, D., Wakefield, A., Egbert, M. E., & Whitty, A. (2018) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2018.05.003 · Cited by 210 · see citing works

A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design

Card, G. L., Blasdel, L. K., England, B. P., Zhang, C., Suzuki, Y., Gillette, S., Fong, D., Ibrahim, P. N., Artis, D. R., Bollag, G. E., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1059 · Cited by 208 · see citing works

Application of Fragment-Based Drug Discovery to Versatile Targets

Li, Q. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00180 · Cited by 201 · see citing works

Structural biology and drug discovery for protein–protein interactions

Jubb, H. C., Higueruelo, A. P., Winter, A., & Blundell, T. L. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.03.006 · Cited by 182 · see citing works

In situclick chemistry: a powerful means for lead discovery

Sharpless, K. B., & Manetsch, R. (2006) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.1.6.525 · Cited by 182 · see citing works

An expanded allosteric network in PTP1B by multitemperature crystallography, fragment screening, and covalent tethering

Keedy, D. A., Hill, Z. B., Biel, J. T., Kang, E., Rettenmaier, T. J., Brandão-Neto, J., Pearce, N. M., von Delft, F., Wells, J. A., & Fraser, J. S. (2018) · eLife · doi:10.7554/elife.36307 · Cited by 178 · see citing works

Comprehensive Mechanistic Analysis of Hits from High-Throughput and Docking Screens against β-Lactamase

Babaoglu, K., Simeonov, A. M., Irwin, J. J., Nelson, M. E., Feng, B. Y., Thomas, C. J., Cancian, L., Costi, M. P., Maltby, D. A., Jadhav, A., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701500e · Cited by 176 · see citing works

Universal Screening Methods and Applications of ThermoFluor®

Cummings, M. D., Farnum, M. A., & Nelen, M. I. (2006) · SLAS DISCOVERY · doi:10.1177/1087057106292746 · Cited by 174 · see citing works

A Fragment-Based Method to Discover Irreversible Covalent Inhibitors of Cysteine Proteases

Kathman, S. G., Xu, Z., & Statsyuk, A. V. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500345q · Cited by 172 · see citing works

Fragment Based Drug Design: From Experimental to Computational Approaches

Kumar, A., Voet, A. R. D., & Zhang, K. Y. J. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712803530467 · Cited by 170 · see citing works

A common allosteric site and mechanism in caspases

Scheer, J. M., Romanowski, M. J., & Wells, J. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602571103 · Cited by 167 · see citing works

State-of-the-art strategies for targeting protein–protein interactions by small-molecule inhibitors

Sheng, C., Dong, G., Miao, Z., Zhang, W., & Wang, W. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00252d · Cited by 165 · see citing works

Docking Interactions Induce Exposure of Activation Loop in the MAP Kinase ERK2

Zhou, T., Sun, L., Humphreys, J., & Goldsmith, E. J. (2006) · Structure · doi:10.1016/j.str.2006.04.006 · Cited by 164 · see citing works

Deconstructing fragment-based inhibitor discovery

Babaoglu, K., & Shoichet, B. K. (2006) · Nature Chemical Biology · doi:10.1038/nchembio831 · Cited by 164 · see citing works

Selective, rapid and optically switchable regulation of protein function in live mammalian cells

Tsai, Y., Essig, S., James, J. R., Lang, K., & Chin, J. W. (2015) · Nature Chemistry · doi:10.1038/nchem.2253 · Cited by 161 · see citing works

A Remote Arene-Binding Site on Prostate Specific Membrane Antigen Revealed by Antibody-Recruiting Small Molecules

Zhang, A. X., Murelli, R. P., Bařinka, C., Michel, J., Cocleaza, A., Jorgensen, W. L., Lubkowski, J. T., & Spiegel, D. A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja104591m · Cited by 161 · see citing works

Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo

Dubiella, C., Pinch, B. J., Koikawa, K., Zaidman, D., Poon, E., Manz, T. D., Nabet, B., He, S., Resnick, E., Rogel, A., et al. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00786-7 · Cited by 161 · see citing works

Structural genomics of protein phosphatases

Almo, S. C., Bonanno, J. B., Sauder, J. M., Emtage, S., DiLorenzo, T. P., Malashkevich, V. N., Wasserman, S. R., Swaminathan, S., Eswaramoorthy, S., Agarwal, R., et al. (2007) · Journal of Structural and Functional Genomics · doi:10.1007/s10969-007-9036-1 · Cited by 158 · see citing works

Turning a protein kinase on or off from a single allosteric site via disulfide trapping

Sadowsky, J., Burlingame, M. A., Wolan, D. W., McClendon, C. L., Jacobson, M. P., & Wells, J. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102376108 · Cited by 154 · see citing works

Inhibitor of MYC identified in a Kröhnke pyridine library

Hart, J. R., Garner, A. L., Yu, J., Ito, Y., Sun, M., Ueno, L. A., Rhee, J., Baksh, M. M., Stefan, E., Hartl, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319488111 · Cited by 149 · see citing works

Therapeutic Targeting of Myc

Prochownik, E. V., & Vogt, P. K. (2010) · Genes & Cancer · doi:10.1177/1947601910377494 · Cited by 149 · see citing works

Fragment-based lead discovery: a chemical update

Erlanson, D. A. (2006) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2006.10.007 · Cited by 149 · see citing works

Harnessing Allostery: A Novel Approach to Drug Discovery

Lu, S., Li, S., & Zhang, J. (2014) · Medicinal Research Reviews · doi:10.1002/med.21317 · Cited by 147 · see citing works

Allosteric Inhibition of the NS2B-NS3 Protease from Dengue Virus

Yıldız, M., Ghosh, S., Bell, J. A., Sherman, W., & Hardy, J. A. (2013) · ACS Chemical Biology · doi:10.1021/cb400612h · Cited by 147 · see citing works

Fragment-based covalent ligand discovery

Lu, W., Kostic, M., Zhang, T., Che, J., Patricelli, M. P., Jones, L. H., Chouchani, E. T., & Gray, N. S. (2021) · RSC Chemical Biology · doi:10.1039/d0cb00222d · Cited by 136 · see citing works

Exploring the structural origins of cryptic sites on proteins

Beglov, D., Hall, D. R., Wakefield, A., Luo, L., Allen, K. N., Kozakov, D., Whitty, A., & Vajda, S. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711490115 · Cited by 136 · see citing works

Quantitative Characterization of the Binding and Unbinding of Millimolar Drug Fragments with Molecular Dynamics Simulations

Pan, A. C., Xu, H., Palpant, T., & Shaw, D. E. (2017) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.7b00172 · Cited by 135 · see citing works

Fragment-Based Lead Discovery and Design

Joseph-McCarthy, D., Campbell, A. J., Kern, G., & Moustakas, D. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci400731w · Cited by 129 · see citing works

Design and NMR-Based Screening of LEF, a Library of Chemical Fragments with Different Local Environment of Fluorine

Vulpetti, A., Hommel, U., Landrum, G. A., Lewis, R. A., & Dalvit, C. (2009) · Journal of the American Chemical Society · doi:10.1021/ja905207t · Cited by 128 · see citing works

Subtiligase-Catalyzed Peptide Ligation

Weeks, A. M., & Wells, J. A. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00372 · Cited by 124 · see citing works

Impact of linker strain and flexibility in the design of a fragment-based inhibitor

Chung, S., Parker, J. B., Bianchet, M. A., Amzel, L. M., & Stivers, J. T. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.163 · Cited by 118 · see citing works

2-Sulfonylpyridines as Tunable, Cysteine-Reactive Electrophiles

Zambaldo, C., Vinogradova, E. V., Qi, X., Iaconelli, J., Suciu, R. M., Koh, M., Senkane, K., Chadwick, S. R., Sanchez, B. B., Chen, J. S., et al. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c02721 · Cited by 117 · see citing works

Creating Protein Affinity Reagents by Combining Peptide Ligands on Synthetic DNA Scaffolds

Williams, B. A. R., Diehnelt, C. W., Belcher, P. E., Greving, M. P., Woodbury, N. W., Johnston, S. A., & Chaput, J. C. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9051735 · Cited by 116 · see citing works

Evolutions in fragment-based drug design: the deconstruction–reconstruction approach

Chen, H., Zhou, X., Wang, A., Zheng, Y., Gao, Y., & Zhou, J. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.09.015 · Cited by 115 · see citing works

Dynamic Combinatorial Chemistry: A New Methodology Comes of Age

Frei, P., Hevey, R., & Ernst, B. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201803365 · Cited by 114 · see citing works

Engineering peptide ligase specificity by proteomic identification of ligation sites

Weeks, A. M., & Wells, J. A. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2521 · Cited by 113 · see citing works

The Design of Covalent Allosteric Drugs

Nussinov, R., & Tsai, C.-J. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124401 · Cited by 112 · see citing works

Ras Binder Induces a Modified Switch-II Pocket in GTP and GDP States

Gentile, D. R., Rathinaswamy, M. K., Jenkins, M. L., Moss, S. M., Siempelkamp, B. D., Renslo, A. R., Burke, J. E., & Shokat, K. M. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.08.025 · Cited by 111 · see citing works

Protein Conformational Populations and Functionally Relevant Substates

Ramanathan, A., Savol, A., Burger, V., Chennubhotla, C. S., & Agarwal, P. K. (2014) · Accounts of Chemical Research · doi:10.1021/ar400084s · Cited by 110 · see citing works

Advantages of crystallographic fragment screening: Functional and mechanistic insights from a powerful platform for efficient drug discovery

Patel, D., Bauman, J. D., & Arnold, E. (2014) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2014.08.004 · Cited by 110 · see citing works

Site-Directed Fragment-Based Screening for the Discovery of Protein–Protein Interaction Stabilizers

Sijbesma, E., Hallenbeck, K. K., Leysen, S., de Vink, P. J., Skóra, L., Jahnke, W., Brunsveld, L., Arkin, M. R., & Ottmann, C. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b11658 · Cited by 110 · see citing works

Unique MAP Kinase binding sites

Akella, R., Moon, T. M., & Goldsmith, E. J. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2007.09.016 · Cited by 108 · see citing works

Targeting Protein–Protein Interactions and Fragment-Based Drug Discovery

Valkov, E., Sharpe, T., Marsh, M., Greive, S., & Hyvönen, M. (2011) · Topics in Current Chemistry · doi:10.1007/128_2011_265 · Cited by 107 · see citing works

Improving Prospects for Targeting RAS

Singh, H., Longo, D. L., & Chabner, B. A. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.62.1052 · Cited by 105 · see citing works

Covalent fragment libraries in drug discovery

Keeley, A. B., Petri, L., Ábrányi‐Balogh, P., & Keserű, G. M. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.03.016 · Cited by 104 · see citing works

Kinetic Stabilization of an Oligomeric Protein by a Single Ligand Binding Event

Wiseman, R. L., Johnson, S. M., Kelker, M. S., Foss, T. R., Wilson, I. A., & Kelly, J. W. (2005) · Journal of the American Chemical Society · doi:10.1021/ja042929f · Cited by 104 · see citing works

Motif mediated protein-protein interactions as drug targets

Corbi‐Verge, C., & Kim, P. M. (2016) · Cell Communication and Signaling · doi:10.1186/s12964-016-0131-4 · Cited by 103 · see citing works

A general fragment-based approach to identify and optimize bioactive ligands targeting RNA

Suresh, B. M., Li, W., Zhang, P., Wang, K. W., Yildirim, I., Parker, C. G., & Disney, M. D. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2012217117 · Cited by 100 · see citing works

Minimal Pharmacophoric Elements and Fragment Hopping, an Approach Directed at Molecular Diversity and Isozyme Selectivity. Design of Selective Neuronal Nitric Oxide Synthase Inhibitors

Ji, H., Stanton, B. Z., Igarashi, J., Li, H., Pavel Martasek, E., Roman, L. J., Poulos, T. L., & Silverman, R. B. (2008) · Journal of the American Chemical Society · doi:10.1021/ja0772041 · Cited by 99 · see citing works

Covalent Small Molecules as Enabling Platforms for Drug Discovery

Dalton, S. E., & Campos, S. (2019) · ChemBioChem · doi:10.1002/cbic.201900674 · Cited by 98 · see citing works

Virtual fragment screening: an exploration of various docking and scoring protocols for fragments using Glide

Kawatkar, S. P., Wang, H., Czermiński, R., & Joseph‐McCarthy, D. (2009) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-009-9281-4 · Cited by 98 · see citing works

Activation and Regulation of Caspase-6 and Its Role in Neurodegenerative Diseases

Wang, X., Cao, Q., Zhang, Y., & Su, X. (2014) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124414 · Cited by 97 · see citing works

Strategies for stabilizing superoxide dismutase (SOD1), the protein destabilized in the most common form of familial amyotrophic lateral sclerosis

Auclair, J. R., Boggio, K. J., Petsko, G. A., Ringe, D., & Agar, J. N. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015463107 · Cited by 93 · see citing works

Metal Ion Site Engineering Indicates a Global Toggle Switch Model for Seven-transmembrane Receptor Activation

Elling, C., Frimurer, T. M., Gerlach, L., Jørgensen, R., Holst, B., & Schwartz, T. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512510200 · Cited by 93 · see citing works

Ligand discovery by activity-based protein profiling

Niphakis, M. J., & Cravatt, B. F. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.08.006 · Cited by 90 · see citing works

DNA-Encoded Chemical Libraries for the Discovery of MMP-3 Inhibitors

Scheuermann, J., Dumelin, C. E., Melkko, S., Zhang, Y., Mannocci, L., Jaggi, M., Sobek, J., & Neri, D. (2008) · Bioconjugate Chemistry · doi:10.1021/bc7004347 · Cited by 90 · see citing works

Covalent Capture: Merging Covalent and Noncovalent Synthesis

Prins, L. J., & Scrimin, P. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200803583 · Cited by 89 · see citing works

Seamless Bead to Microarray Screening: Rapid Identification of the Highest Affinity Protein Ligands from Large Combinatorial Libraries

Astle, J. M., Simpson, L. S., Huang, Y., Reddy, M. M., Wilson, R. W., Connell, S., Wilson, J., & Kodadek, T. J. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.12.015 · Cited by 88 · see citing works

Integrating Fragment Assembly and Biophysical Methods in the Chemical Advancement of Small-Molecule Antagonists of IL-2: An Approach for Inhibiting Protein−Protein Interactions

Raimundo, B. C., Oslob, J. D., Braisted, A. C., Hyde, J., McDowell, R. S., Randal, M., Waal, N. D., Wilkinson, J., Yu, C. H., & Arkin, M. R. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049967u · Cited by 86 · see citing works

Solution Nuclear Magnetic Resonance Spectroscopy Techniques for Probing Intermolecular Interactions

Pellecchia, M. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.08.013 · Cited by 86 · see citing works

Covalent tethering of fragments for covalent probe discovery

Kathman, S. G., & Statsyuk, A. V. (2016) · MedChemComm · doi:10.1039/c5md00518c · Cited by 85 · see citing works

Discovery of a potent and highly selective PDK1 inhibitor via fragment-based drug discovery

Erlanson, D. A., Arndt, J. W., Cancilla, M. T., Cao, K., Elling, R. A., English, N., Friedman, J., Hansen, S. K., Hession, C., Joseph, I. B. J., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.03.032 · Cited by 84 · see citing works

Fragment Informatics and Computational Fragment‐Based Drug Design: An Overview and Update

Sheng, C., & Zhang, W. (2013) · Medicinal Research Reviews · doi:10.1002/med.21255 · Cited by 80 · see citing works

Identification of Cys255 in HIF‐1α as a novel site for development of covalent inhibitors of HIF‐1α/ARNT PasB domain protein–protein interaction

Cardoso, R., Love, R., Nilsson, C. L., Bergqvist, S., Nowlin, D., Yan, J., Liu, K. K. ‐., Zhu, J., Chen, P., Deng, Y., et al. (2012) · Protein Science · doi:10.1002/pro.2172 · Cited by 79 · see citing works

Inhibiting transient protein–protein interactions: lessons from the Cdc25 protein tyrosine phosphatases

Rudolph, J. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2087 · Cited by 79 · see citing works

Modulating the masters: chemical tools to dissect CBP and p300 function

Breen, M. E., & Mapp, A. K. (2018) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2018.06.005 · Cited by 77 · see citing works

Design of compound libraries for fragment screening

Blomberg, N., Cosgrove, D. A., Kenny, P. W., & Kolmodin, K. (2009) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-009-9264-5 · Cited by 75 · see citing works

Exploring the Subtleties of Drug−Receptor Interactions: The Case of Matrix Metalloproteinases

Bertini, I., Calderone, V., Fragai, M., Giachetti, A., Loconte, M., Luchinat, C., Maletta, M., Nativi, C., & Yeo, K. J. (2007) · Journal of the American Chemical Society · doi:10.1021/ja065156z · Cited by 75 · see citing works

A tethering mechanism for length control in a processive carbohydrate polymerization

May, J. F., Splain, R. A., Brotschi, C., & Kiessling, L. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901407106 · Cited by 75 · see citing works

Ligand deconstruction: Why some fragment binding positions are conserved and others are not

Kozakov, D., Hall, D. R., Jehle, S., Luo, L., Ochiana, S. O., Jones, E. V., Pollastri, M. P., Allen, K. N., Whitty, A., & Vajda, S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501567112 · Cited by 74 · see citing works

Fragment‐Based Drug Discovery at Adaptive Protein Sites

Erlanson, D. A. (2007) · The FASEB Journal · doi:10.1096/fasebj.21.5.a209-b

Tethering in early target assessment

Oslob, J. D., & Erlanson, D. A. (2004) · Drug Discovery Today TARGETS · doi:10.1016/s1741-8372(04)02441-7 · Cited by 11 · see citing works

TETHERING: A NOVEL TOOL IN DRUG DISCOVERY

Rupali, Y., Jagdale, D. M., & Vilasrao, K. (2014) · Indo American Journal of Pharmaceutical Research

Probing structural adaptivity at PPI interfaces with small molecules

Wilson, C. G. M., & Arkin, M. R. (2012) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2012.10.009 · Cited by 22 · see citing works

Making drugs on proteins: site-directed ligand discovery for fragment-based lead assembly

Erlanson, D. A., & Hansen, S. K. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.06.010 · Cited by 61 · see citing works